Myeloma Marketplace

Myeloma Marketplace

Select a category or use the search box below to find a product.


Understanding Empliciti® (elotuzumab)
Understanding Empliciti® (elotuzumab)

Empliciti® (elotuzumab) is the first immunostimulatory monoclonal antibody approved for the treatment of myeloma. Empliciti enlists immune system cells to attack myeloma. Before reading this booklet, it may be helpful to read another IMF publication, Understanding the Immune System in myeloma.
Purchase this product
FREE